Literature DB >> 27112301

Historical developments of atrial septal defect closure devices: what we learn from the past.

Martina Nassif1, Mohammad Abdelghani1, Berto J Bouma1, Bart Straver2, Nico A Blom2, Karel T Koch1, Jan G P Tijssen1, Barbara J M Mulder1,3, Robbert J de Winter1.   

Abstract

INTRODUCTION: Since King and Mills' pioneering work in percutaneous closure devices of secundum atrial septal defects (ASD) four decades ago, developments in device shape, material and implantation technique led to adoption of percutaneous ASD closure as current treatment of choice. Not only was the feasibility of such a percutaneous procedure tested altogether, but pursuing the ideal device in terms of safety and efficacy became priority. AREAS COVERED: In this review we present the historical development of ASD devices in design, material and technique with clinical data, and provide the future perspectives in percutaneous ASD closures. EXPERT OPINION: An 'ideal device' requires complete defect closure with negligible risk of complications using a safe, straightforward delivery technique with repositioning and retrieving properties. Some of the devices currently at hand come close to fulfilling these criteria, however none seem to provide those prerequisites completely. By understanding how challenges in device development were overcome in the past, new insights into future improvements are given.

Entities:  

Keywords:  Heart septal defects; atrial; congenital heart disease; device closure; grown ups with congenital heart disease; percutaneous non-coronary interventions; septal occluders

Mesh:

Year:  2016        PMID: 27112301     DOI: 10.1080/17434440.2016.1182860

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN: 1743-4440            Impact factor:   3.166


  7 in total

Review 1.  Transcatheter closure of atrial septal defect: principles and available devices.

Authors:  Se Yong Jung; Jae Young Choi
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 2.  Atrial septal defect (ASD) device trans-catheter closure: limitations.

Authors:  Alessia Faccini; Gianfranco Butera
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

3.  Study of biodegradable occluder of atrial septal defect in a porcine model.

Authors:  Bo-Ning Li; Yu-Mei Xie; Zhao-Feng Xie; Xian-Miao Chen; Gui Zhang; De-Yuan Zhang; Xiang-Dong Liu; Zhi-Wei Zhang
Journal:  Catheter Cardiovasc Interv       Date:  2018-09-09       Impact factor: 2.692

4.  Completed atrioventricular block induced by atrial septal defect occluder unfolding: A case report.

Authors:  Chuan He; Yang Zhou; Si-Si Tang; Li-Hong Luo; Kun Feng
Journal:  World J Clin Cases       Date:  2020-11-26       Impact factor: 1.337

5.  Preliminary Experience With the New Amplatzer™ Trevisio™ Delivery System in Transcatheter Atrial Septal Defect Closures in Children.

Authors:  Raymond N Haddad; Diala Khraiche; Damien Bonnet; Mathilde Meot; Sophie Malekzadeh-Milani
Journal:  Front Pediatr       Date:  2021-03-11       Impact factor: 3.418

6.  A multi-center trial on efficacy and safety of the LifeTech CeraFlexTM ASD occluder for transcatheter closure in patients with secundum atrial septal defects.

Authors:  Celina Fritz; Andrea Engelhardt; Jochen Grohmann; Ingo Dähnert; Johanna Hummel; Daniel Tanase; Peter Ewert; Andreas Eicken
Journal:  Cardiovasc Diagn Ther       Date:  2022-08

7.  Minimally invasive versus transcatheter closure of secundum atrial septal defects: a systematic review and meta-analysis.

Authors:  Esther Goh; Haya Mohammed; Mohammad Yusuf Salmasi; Samantha Ho; Umberto Benedetto; Massimo Caputo; Gianni Angelini; Hunaid A Vohra
Journal:  Perfusion       Date:  2021-06-10       Impact factor: 1.581

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.